PhRMA's Narasimhan Asks Japan To Reform Pricing Policies

Phase I Waiver Plan 'Very Positive'

 
• By Lisa Takagi
  
Vassant Narashimhan, Chair of the PhRMA Board of Directors at press conference in Tokyo, Japan
Vasant Narashimhan, Chair of the PhRMA Board of Directors at press conference in Tokyo, Japan • Source: Lisa Takagi
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Japan

More from Asia